SARS-CoV-2 binding and neutralizing antibody levels after Ad26.COV2.S vaccination predict durable protection in rhesus macaques

Several COVID-19 vaccines have recently gained authorization for emergency use. Limited knowledge on duration of immunity and efficacy of these vaccines is currently available. Data on other coronaviruses after natural infection suggest that immunity to SARS-CoV-2 might be short-lived, and prelimina...

Descripción completa

Detalles Bibliográficos
Autores principales: Roozendaal, Ramon, Solforosi, Laura, Stieh, Daniel J., Serroyen, Jan, Straetemans, Roel, Dari, Anna, Boulton, Muriel, Wegmann, Frank, Rosendahl Huber, Sietske K., van der Lubbe, Joan E. M., Hendriks, Jenny, Le Gars, Mathieu, Dekking, Liesbeth, Czapska-Casey, Dominika N., Guimera, Nuria, Janssen, Sarah, Tete, Sarah, Chandrashekar, Abishek, Mercado, Noe B., Yu, Jingyou, Koudstaal, Wouter, Perez-Ruixo, Juan J., Sadoff, Jerry, Barouch, Dan H., Schuitemaker, Hanneke, Zahn, Roland
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8497464/
https://www.ncbi.nlm.nih.gov/pubmed/34620860
http://dx.doi.org/10.1038/s41467-021-26117-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8497464/
https://www.ncbi.nlm.nih.gov/pubmed/34620860
http://dx.doi.org/10.1038/s41467-021-26117-x

Ejemplares similares